Company Valuation: Scinai Immunotherapeutics Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 32.38 43.42 10.32 2.591 2.853 2.47
Change - 34.08% -76.24% -74.88% 10.12% -13.44%
Enterprise Value (EV) 1 90.12 59.12 17.78 18.28 2.975 3.076
Change - -34.4% -69.92% 2.8% -83.73% 3.38%
P/E - - - - - -0.2x
PBR - - - -0.61x 0.66x 1x
PEG - - - - - -
Capitalization / Revenue - - - - 4,336,096x 1,883,833x
EV / Revenue - - - - - -
EV / EBITDA 10.2x -1.77x -1.69x -1.99x -0.43x -0.5x
EV / EBIT 12.3x -1.7x -1.61x -1.88x -0.34x -0.41x
EV / FCF -14.9x -4.18x -2.07x -3.1x -0.78x -0.92x
FCF Yield -6.7% -23.9% -48.2% -32.3% -128% -108%
Dividend per Share 3 - - - - - -
Rate of return - - - - - -
EPS 3 - - - - - -142.3
Distribution rate - - - - - -
Net sales - - - - 0.658 1.311
EBITDA 1 8.84 -33.31 -10.5 -9.192 -6.989 -6.121
EBIT 1 7.334 -34.83 -11.06 -9.706 -8.638 -7.542
Net income 1 -4.455 -39.98 -5.796 -6.5 4.796 -8.307
Net Debt 1 57.74 15.7 7.467 15.69 0.122 0.606
Reference price 3 11,240.000 9,400.000 1,184.000 238.160 133.800 28.484
Nbr of stocks (in thousands) 2.88 4.62 8.71 10.9 21.3 86.7
Announcement Date 5/13/21 A 3/28/22 A 4/17/23 A 5/15/24 A 5/7/25 A 4/1/26 A
1USD in Million2ILS in Million3USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 535K
16.7x6.32x12.11x1.79% 63.66B
31.66x8.45x27.93x0.07% 58.56B
37.7x6.72x20.09x0.86% 54.19B
40.47x5.8x27.69x-.--% 44.66B
32.09x3.11x13.42x-.--% 40.51B
36.32x8.88x23.19x0.36% 36.27B
-19.54x51.81x-20.9x-.--% 34.87B
41.15x7.94x26.62x-.--% 32.26B
-87.55x16.38x-94.1x-.--% 31.01B
Average 14.33x 12.82x 4.00x 0.34% 40B
Weighted average by Cap. 18.48x 11.46x 8.41x 0.45%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Scinai Immunotherapeutics Ltd.

Historical PBR trend

Valuation ratios - PBR - Scinai Immunotherapeutics Ltd.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Scinai Immunotherapeutics Ltd.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Scinai Immunotherapeutics Ltd.

  1. Stock Market
  2. Stocks
  3. SCNI Stock
  4. Valuation Scinai Immunotherapeutics Ltd.